Prognosis, clinicopathological characteristics, and treatment patterns of patients with ER-intermediate-positive breast cancer undergoing long-term follow-up
Patients with ER-intermediate-positive breast cancer differ from patients with ER-high-positive breast cancer, suggesting that the treatment of ER-positive breast cancer patients should be tailored based on ER expression levels.
Authors
- Yumi Wanifuchi‐Endo (ORCID: https://orcid.org/0000-0002-0703-2289)
- Hiroyuki Kato (ORCID: https://orcid.org/0000-0002-7663-9404)
- Akiko Isogai
- Tatsuya Toyama (ORCID: https://orcid.org/0000-0003-4713-7795)
- Mitsuo Terada (ORCID: https://orcid.org/0000-0002-1304-2619)
- Makiko Mori (ORCID: https://orcid.org/0000-0003-3427-2461)
- Yoshimitsu Niwa
- Tomoko Asano (ORCID: https://orcid.org/0009-0002-7929-3848)
- Naoya Matsumoto (ORCID: https://orcid.org/0000-0002-4887-6920)
- Takashi Fujita
- Kazuki Nozawa (ORCID: https://orcid.org/0000-0002-0277-8196)
- Masayoshi Komura
Institutions
- Nagoya City University (JP)
Publication Details
- Journal
- ESMO Open
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1016/j.esmoop.2025.104508
- Citations
- 5
- Primary Topic
- Advanced Breast Cancer Therapies
- Type
- article
- Field-Weighted Citation Impact
- 7.59
Funders
- Japan Society for the Promotion of Science